Trueblue Stock Performance
TBI Stock | USD 7.10 0.14 2.01% |
On a scale of 0 to 100, TrueBlue holds a performance score of 15. The entity has a beta of 1.32, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TrueBlue will likely underperform. Please check TrueBlue's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether TrueBlue's existing price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in TrueBlue are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, TrueBlue demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.01 | Five Day Return 14.15 | Year To Date Return (9.44) | Ten Year Return (75.20) | All Time Return 1.6 K |
Last Split Factor 3:2 | Last Split Date 1999-07-13 |
1 | TrueBlues Centerline Drivers Launches Inaugural Customer Awards to Elevate Recognition of Excellence in Transportation | 05/08/2025 |
2 | TrueBlues PeopleReady Brand Recognized for Excellence in Technology Innovation with Proprietary JobStack App | 05/14/2025 |
3 | TrueBlue Rejects HireQuests 7.50 Share Offer - CEO Hints at Higher Bid with Cash Component - Stock Titan | 05/19/2025 |
4 | TrueBlues PeopleScout Wins 2025 American Business Award for Affinix Talent Technology | 05/28/2025 |
5 | TrueBlue Recognized by Forbes for Temporary Staffing Excellence Based on Evaluation from Buyers and Workers | 06/05/2025 |
6 | TrueBlue Recognized for MSP Leadership by HRO Today on 2025 Bakers Dozen | 06/09/2025 |
7 | Disposition of 722 shares by Richard Christensen of TrueBlue at 13.68 subject to Rule 16b-3 | 06/13/2025 |
8 | Bioxytran Secures a Source of GMP Quality Camel Hemoglobin | 06/18/2025 |
9 | TrueBlue Recognized for RPO Leadership in Everest Groups RPO PEAK Matrix | 07/02/2025 |
10 | Invisible Wounds Foundation Appoints Internationally Renowned TBI Expert as Its Chief Medical Scientist | 07/10/2025 |
Begin Period Cash Flow | 99.3 M | |
Total Cashflows From Investing Activities | -2.5 M |
TrueBlue Relative Risk vs. Return Landscape
If you would invest 437.00 in TrueBlue on April 22, 2025 and sell it today you would earn a total of 273.00 from holding TrueBlue or generate 62.47% return on investment over 90 days. TrueBlue is generating 0.8634% of daily returns assuming volatility of 4.3427% on return distribution over 90 days investment horizon. In other words, 38% of stocks are less volatile than TrueBlue, and above 83% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
TrueBlue Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TrueBlue's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TrueBlue, and traders can use it to determine the average amount a TrueBlue's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1988
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | TBI | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.34 actual daily | 38 62% of assets are more volatile |
Expected Return
0.86 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average TrueBlue is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TrueBlue by adding it to a well-diversified portfolio.
TrueBlue Fundamentals Growth
TrueBlue Stock prices reflect investors' perceptions of the future prospects and financial health of TrueBlue, and TrueBlue fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TrueBlue Stock performance.
Return On Equity | -0.37 | ||||
Return On Asset | -0.0331 | ||||
Profit Margin | (0.09) % | ||||
Operating Margin | (0.04) % | ||||
Current Valuation | 304.19 M | ||||
Shares Outstanding | 29.86 M | ||||
Price To Earning | 47.57 X | ||||
Price To Book | 0.70 X | ||||
Price To Sales | 0.14 X | ||||
Revenue | 1.57 B | ||||
Gross Profit | 390.5 M | ||||
EBITDA | (3.54 M) | ||||
Net Income | (125.75 M) | ||||
Cash And Equivalents | 22.54 M | ||||
Cash Per Share | 1.34 X | ||||
Total Debt | 66.53 M | ||||
Debt To Equity | 0.13 % | ||||
Current Ratio | 1.83 X | ||||
Book Value Per Share | 10.13 X | ||||
Cash Flow From Operations | (17.06 M) | ||||
Earnings Per Share | (4.60) X | ||||
Market Capitalization | 212.03 M | ||||
Total Asset | 675.38 M | ||||
Retained Earnings | 337.55 M | ||||
Working Capital | 116.97 M | ||||
Current Asset | 542.97 M | ||||
Current Liabilities | 227.98 M | ||||
About TrueBlue Performance
By evaluating TrueBlue's fundamental ratios, stakeholders can gain valuable insights into TrueBlue's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if TrueBlue has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TrueBlue has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 8.45 | 5.54 | |
Return On Tangible Assets | (0.02) | (0.02) | |
Return On Capital Employed | (0.03) | (0.03) | |
Return On Assets | (0.02) | (0.02) | |
Return On Equity | (0.04) | (0.03) |
Things to note about TrueBlue performance evaluation
Checking the ongoing alerts about TrueBlue for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TrueBlue help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.TrueBlue appears to be risky and price may revert if volatility continues | |
The company reported the last year's revenue of 1.57 B. Reported Net Loss for the year was (125.75 M) with profit before taxes, overhead, and interest of 390.5 M. | |
TrueBlue has about 22.54 M in cash with (17.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.34. | |
Over 96.0% of the company shares are owned by institutional investors | |
Latest headline from prnewswire.com: Invisible Wounds Foundation Appoints Internationally Renowned TBI Expert as Its Chief Medical Scientist |
- Analyzing TrueBlue's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TrueBlue's stock is overvalued or undervalued compared to its peers.
- Examining TrueBlue's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TrueBlue's management team can have a significant impact on its success or failure. Reviewing the track record and experience of TrueBlue's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TrueBlue's stock. These opinions can provide insight into TrueBlue's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for TrueBlue Stock analysis
When running TrueBlue's price analysis, check to measure TrueBlue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TrueBlue is operating at the current time. Most of TrueBlue's value examination focuses on studying past and present price action to predict the probability of TrueBlue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TrueBlue's price. Additionally, you may evaluate how the addition of TrueBlue to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |